Annual Total Long Term Liabilities
$68.90 M
+$15.81 M+29.78%
December 31, 2023
Summary
- As of February 21, 2025, ARCT annual total long term liabilities is $68.90 million, with the most recent change of +$15.81 million (+29.78%) on December 31, 2023.
- During the last 3 years, ARCT annual total long term liabilities has risen by +$38.52 million (+126.78%).
- ARCT annual total long term liabilities is now at all-time high.
Performance
ARCT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$39.33 M
+$1.02 M+2.65%
September 30, 2024
Summary
- As of February 21, 2025, ARCT quarterly total long term liabilities is $39.33 million, with the most recent change of +$1.02 million (+2.65%) on September 30, 2024.
- Over the past year, ARCT quarterly long term liabilities has stayed the same.
- ARCT quarterly long term liabilities is now -56.26% below its all-time high of $89.91 million, reached on September 30, 2023.
Performance
ARCT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ARCT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.8% | 0.0% |
| 3 y3 years | +126.8% | -25.9% |
| 5 y5 years | +283.2% | -25.9% |
ARCT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.8% | -56.3% | +2.6% |
| 5 y | 5-year | at high | +126.8% | -56.3% | +29.4% |
| alltime | all time | at high | -100.0% | -56.3% | -100.0% |
Arcturus Therapeutics Holdings Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $39.33 M(+2.7%) |
| Jun 2024 | - | $38.31 M(-2.9%) |
| Mar 2024 | - | $39.45 M(-42.7%) |
| Dec 2023 | $68.90 M(+29.8%) | $68.90 M(-23.4%) |
| Sep 2023 | - | $89.91 M(+63.1%) |
| Jun 2023 | - | $55.13 M(+7.1%) |
| Mar 2023 | - | $51.48 M(-3.0%) |
| Dec 2022 | $53.09 M(-18.4%) | $53.09 M(-26.4%) |
| Sep 2022 | - | $72.11 M(-2.0%) |
| Jun 2022 | - | $73.55 M(+47.3%) |
| Mar 2022 | - | $49.93 M(-23.3%) |
| Dec 2021 | $65.07 M(+114.2%) | $65.07 M(+13.8%) |
| Sep 2021 | - | $57.17 M(-21.0%) |
| Jun 2021 | - | $72.40 M(-4.1%) |
| Mar 2021 | - | $75.53 M(+148.6%) |
| Dec 2020 | $30.38 M(-13.3%) | $30.38 M(-7.6%) |
| Sep 2020 | - | $32.88 M(-1.8%) |
| Jun 2020 | - | $33.47 M(-0.0%) |
| Mar 2020 | - | $33.47 M(-4.4%) |
| Dec 2019 | $35.03 M(+94.8%) | $35.03 M(+18.2%) |
| Sep 2019 | - | $29.63 M(-10.0%) |
| Jun 2019 | - | $32.91 M(+40.3%) |
| Mar 2019 | - | $23.45 M(+30.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $17.98 M(+150.1%) | $17.98 M(+92.0%) |
| Sep 2018 | - | $9.36 M(+13.2%) |
| Jun 2018 | - | $8.27 M(+15.1%) |
| Dec 2017 | $7.19 M(+109.9%) | $7.19 M(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $3.42 M(>+9900.0%) | $3.42 M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00 |
| Dec 2011 | $0.00 | - |
FAQ
- What is Arcturus Therapeutics Holdings annual total long term liabilities?
- What is the all time high annual total long term liabilities for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual total long term liabilities year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly long term liabilities year-on-year change?
What is Arcturus Therapeutics Holdings annual total long term liabilities?
The current annual total long term liabilities of ARCT is $68.90 M
What is the all time high annual total long term liabilities for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual total long term liabilities is $68.90 M
What is Arcturus Therapeutics Holdings annual total long term liabilities year-on-year change?
Over the past year, ARCT annual total long term liabilities has changed by +$15.81 M (+29.78%)
What is Arcturus Therapeutics Holdings quarterly total long term liabilities?
The current quarterly long term liabilities of ARCT is $39.33 M
What is the all time high quarterly long term liabilities for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly total long term liabilities is $89.91 M
What is Arcturus Therapeutics Holdings quarterly long term liabilities year-on-year change?
Over the past year, ARCT quarterly total long term liabilities has changed by $0.00 (0.00%)